Medicines | European Medicines Agency

Medicines

For help on how to get the results you want, see our search tips.

Search results

Categories

Medicine name

Active substance / international non-proprietary name (INN) / common name

Medicine

Product number

Opinion status

Application type

Date of opinion

Medicine type

Related medicine

Therapeutic area

Last updated

First published

1 results

Sort by

List item

Summary of opinion: Rybrevant (new)

amivantamab, opinion date: 14/10/2021, Positive, Last updated: 15/10/2021